Making medical science work for everyone
- You are here:
- Publications
Publications
Featured publications
Your results
Filter by
Sorry, no results found.
Consultation responses, letters and statements
-
Briefing: Removing barriers to legitimate research using controlled substances
-
Academy of Medical Sciences response to R&D Roadmap consultation 2020
-
Letter to The Baroness Brown of Cambridge DBE FREng FRS from Professor Paul Stewart FMedSci
-
Written submission to Clinical academics in the NHS inquiry
-
Submission to Spring Budget 2023
-
AMS response to inquiry into People and skills in UK STEM
-
Letter of congratulations on the appointment of the Women's Health Ambassador for England
-
COVID-19: what next?
-
Response to the DHSC consultation on the Government's mental health and wellbeing plan - public summary
-
Response to the DHSC consultation on the Government's mental health and wellbeing plan
-
Letter to Medical Research Council on use of both sexes in experimental design
-
Response to MHRA's consultation on legislative changes for clinical trials
-
Statement on embedding public involvement in health and social care research
-
Cross-funder statement on COVID-19 in future grant applications
-
Response to the MHRA consultation on the future regulation of medical devices in the United Kingdom
-
Response to Science and Technology Commons Committee inquiry on reproducibility and research integrity
-
Response to the DHSC draft data strategy for health and social care
-
Response to the Nuffield Council on Bioethics future of ageing call for evidence
-
Response to APPG on Access to Medicines and Medical Devices inquiry
-
Response to the MHRA Patient Involvement Strategy consultation
-
Response to House of Commons' International Development Select Committee inquiry into the future of UK aid
-
Response to DHSC's Women's Health Strategy call for evidence
-
Letter to the Chair of the House of Lords Science and Technology
-
Response to Health and Social Care Committee White Paper consultation
-
Response to the Department for Health and Social Care 'Transforming public health' consultation
-
Letter in response to the MHRA Draft guidance on randomised controlled trials generating real-world evidence to support regulatory decisions
-
Response to Care Quality Commission Strategy review
-
Response to Independent Monitor for the Press Code Review
-
Letter to the Chancellor of the Exchequer from the Presidents of the National Academies
-
Response to APPG inquiry on equity in the STEM workforce
-
Response to Budget 2021
-
Response to the National Data Guardian's Caldicott Principles consultation
-
Joint Academies response to the National Data Strategy consultation
-
Response to Health and Social Care Committee consultation on ‘Workforce burnout and resilience in the NHS and social care’
-
Response to House of Commons Science and Technology Committee consultation on ‘UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks’
-
Response to the role of technology, research and innovation in the COVID-19 recovery
-
Health co-benefits of policies to tackle climate change: Lancet commentary
-
Letter to the Foreign Secretary from the Presidents of the National Academies
-
Joint statement on 'A thriving UK life sciences research sector to accelerate recovery'
-
Lessons learnt: the role of academia and industry in the UK’s diagnostic testing response to COVID-19 – Academy statement
-
Response to the Shape of Training report by Professor David Greenaway
-
Letter to the Secretary of State for Health and Social Care
-
Mental health research goals 2020-2030
-
Statement from Clinical Academic Training Forum on 'Addressing the challenges of COVID-19 second wave'
-
Response to Spending Review 2020
-
Joint AMS-MQ statement on mental health research
-
Joint statement on UK visa costs
-
Statement on the use of animals in research
-
Joint AMS-MQ call for action on mental health science and COVID-19
-
Letter to the Prime Minister from the Academy President
-
Cross-funder multimorbidity research framework
-
Letter to Chair of the Migration Advisory Committee on salary thresholds
-
Response to the House of Lords S&T Committee consultation on ageing, technology and healthy living
-
Response to APPG on access to medicines and medical devices consultation on NICE methods review
-
Response to 'Advancing our health prevention in the 2020s' green paper
-
Response to the HRA consultation on clinical trials transparency
-
Letter to the Prime Minister from the UK National Academies
-
Letter to Sajid Javid from National Academy Presidents 03-06-19
-
Response to the Smith Review into future frameworks for international collaboration on research and innovation
-
Response to the Science and Technology Committee’s inquiry into commercial genomics
-
Joint Academies explainer: Role of research and development tax reliefs play in UK R&D
-
Non-monetary benefits of the EU Framework Programmes
-
Response to the S&T committee inquiry into research and innovation spending
-
Response to S&T Committee inquiry into Brexit, Science and Innovation: Preparations for 'No-Deal'
-
Joint letter to the Secretary of State about our data-driven future health care
-
Letter to the Home Secretary highlighting the importance of international mobility for research and innovation
-
Response to Wellcome's consultation on oversight of emergent science and technology
-
Women in STEM careers: Response to House of Commons Science & Technology Committee inquiry 2013
-
Statement - “No deal” Brexit jeopardises UK medical research
-
Response to House of Commons S&T committee Brexit summit
-
Response to DCMS consultation on the Centre for Data Ethics and Innovation
-
Academy input into the Research and Innovation workstream of NHS England’s Long Term Plan
-
Response to the LSE-Lancet Commission on the future of the NHS
-
Joint submission from the UK national Academies the House of Commons Science and Technology Committee inquiry on an immigration system that works for science and innovation
-
Academy submission to Future Partnership Project
-
A Future Partnership Project statement
-
Academy letter in response to Health Education England Consultation: Facing the Facts, Shaping the Future
-
Response to NHS England consultation on supporting research in the NHS
-
Response to Royal Society & Wellcome Trust consultation on future UK-EU partnership
-
Response to BEIS committee inquiry into Brexit and business for pharmaceuticals
-
Response to the joint Commons Committees inquiry into improving air quality
-
Response to the Migration Advisory Committee call for evidence
-
Joint response to NHS England consultation on CCG prescribing guidance
-
Response to the House of Commons S&T Committee inquiry on science budget and the Industrial Strategy
-
Response to Health Committee inquiry on Brexit – medicines, medical devices and substances of human origin
-
Supplementary response to House of Commons S&T Committee inquiry into genomics in the NHS
-
Response to the House of Lords Artificial Intelligence Committee call for evidence
-
Supplementary response to the S&T committee inquiry on research integrity
-
Academy submission to the Science and Technology Committee (Lords) inquiry into Life Sciences and the Industrial Strategy
-
Submission to the Nuffield Council on Bioethics call for evidence on genome editing
-
Submission to the GMC Medical Licensing Assessment consultation
-
Submission to the House of Commons S&T committee inquiry on algorithms in decision-making
-
Response to consultation on the Industrial Strategy Green Paper
-
Response to consultation on the second Research Excellence Framework
-
Academy response to research integrity inquiry
-
Joint response to Information Commissioner’s Office Consultation: GDPR Consent Guidance
-
Response to the consultation on the updated IPSO Editor’s Code of Practice
-
Joint Academies response to HOC International Development Committee inquiry into UK aid: other government departments
-
Joint submission to the House of Commons Home Affairs Committee inquiry on immigration
-
Informing the Life Sciences Industrial Strategy discussion
-
Response to the Science and Technology Committee inquiry into genomics and genome-editing
-
Response to House of Commons inquiry on UK negotiation objectives for exiting the EU
-
Response to the Science and Technology Committee inquiry on closing the STEM skills gap
-
Open for business - summary
-
Open for business - joint Academies statement
-
Submission to British Academy and Royal Society’s call for evidence on data governance
-
Response to House of Commons inquiry on priorities for health and social care during Brexit negotiations
-
Research reproducibility - progress update from symposium sponsors
-
Academy submission to the HoC S&T Committee inquiry into managing intellectual property and technology transfer
-
UK stakeholder statement on EU DPR implementation, October 2016
-
EU level statement on EU DPR implementation, October 2016
-
National Academies Response_Role and Priorities of UKRI Interim Chair
-
Joint Academy factsheet on UK research and innovation, 2016
-
IAP for Health Statement on Reproducibility 2016
-
IAP for Health Statement on Reproducibility
-
Response to Department of Health consultation on the NDG review of data security, consent and opt-outs
-
Submission to Public Bill Committee for HE & Research Bill
-
Response to the Scottish Parliament inquiry on Brexit
-
Statement on guidance documents for implementation of the Clinical Trials Regulation
-
Academy submission to the 'Leaving the EU' inquiry
-
National Academies Commons Committee stage briefing on the Higher Education and Research Bill
-
Joint statement - Science is Global
-
Academies statement on the EU referendum
-
Higher Education and Research Bill briefing
-
Response to the Department of Business, Innovation and Skills consultation on a National Innovation Plan
-
Academy submission to the S&T Committee inquiry on regenerative medicine
-
Letter to Public Accounts Committee on science capital spend consultation
-
Response to the House of Commons S&T Committee inquiry into science communication
-
Response to the House of Commons inquiry on the impact of EU membership on UK health policy
-
Response to the HRA consultation on the draft UK policy framework for health and social care research
-
Academy submission to the REF Review
-
Submission to inquiry on EU regulation of the life sciences
-
Joint Academies letter on MAC report
-
Response to consultation on Innovate UK’s integration with Research UK
-
Academy submission to Green Paper consultation
-
Academy letter on the Accelerated Access Review interim report
-
Submission to the Department of Health’s consultation on the Government’s mandate to NHS England
-
Academy submission to EU inquiry
-
Letter to The Times on EU Data Protection Regulation
-
Statement on the protection of animals used for scientific purposes
-
Academy response to Home Office letter on the Psychoactive Substances Bill (03/11/15)
-
Research reproducibility: joint statement, October 2015
-
Letter from the Home Office on the Psychoactive Substances Bill (26/10/15)
-
Briefing on the Access to Medical Treatments (Innovation) Bill
-
Joint response to the ‘Science in Emergencies: UK lessons from Ebola’ inquiry
-
Overarching Sector Statement to MAC
-
National Academies response to MAC Wider Review of Tier 2
-
Submission to the Productivity Plan inquiry
-
Submission to the Science Budget inquiry
-
Response to HM Treasury Spending Review call for evidence
-
Spending Review Letter Signatories
-
Response to the Home Affairs Committee inquiry into psychoactive substances
-
Response to the Health Research Authority's draft framework for health and social care research
-
Joint statement on climate change
-
Psychoactive Substances Bill - Letter from the Home Office (14/07/15)
-
Academy submission to consultation on Tier 2 visa salary thresholds
-
Letter to Home Secretary on the Research and Psychoactive Substances bill
-
Letter to the Home Secretary regarding the Research and Psychoactive Substances Bill
-
Joint statement on Data Protection Regulation negotiations
-
Dinner with Dame Ann Dowling: meeting note
-
Statement supporting EU Directive 2010/63/EU on the protection of animals used for scientific purposes
-
Academy submission to the review of the Research Councils by Sir Paul Nurse
-
Joint statement on genetic testing in IVD regulation
-
Draft standards for medical education and training: General Medical Council consultation
-
Consultation by Dame Ann Dowling on business-university collaboration
-
Medical Innovation Bill briefing note 6 March 2015
-
IAMP Statement on Hearing Loss
-
Human Fertilisation and Embryology (Mitochondrial Donation) Regulations briefing note for House of Lords debate
-
UK statement regarding the European Fund for Strategic Investment
-
Response to the Shape of Training review
-
Joint Academies' Statement: Building a Stronger Future
-
Team science: project update
-
Joint statement on the Medical Innovation Bill House of Lords Third Reading
-
A letter from Professor Martin Humphries FMedSci
-
Joint statement on the Medical Innovation Bill House of Lords Report Stage
-
Response to the Health Research Authority’s consultation on seeking informed consent for simple and efficient NHS trials
-
Response to HEFCE consultation on an international REF
-
Joint response to the European Commission’s consultation on the Europe 2020 strategy
-
Medical Innovation Bill briefing note 24 October 2014
-
Research Facts Handout
-
National Academies handout for party conferences - Who we are and what we do
-
Triennial Review of the Animals in Science Committee
-
Science and Innovation Strategy 2014: Supplementary Academy response to BIS consultation
-
Response to the Department of Health consultation on protecting health and care data
-
'One Nation Labour’s Plan for Science': Academy response
-
Science and Innovation Strategy 2014: Joint Academies response to BIS consultation
-
Briefing notes for the Medical Innovation Bill
-
Letter regarding the EU Chief Scientific Adviser, July 2014
-
'Science and research: proposals for long-term capital investment': joint Academies consultation response
-
Letter to BMJ Editor regarding article on animal research
-
MOJ EU Balance of Competences on information rights: Academy response (2014)
-
Health Education England (HEE) Research and Innovation Strategy Stakeholder Response
-
UKBSC response to HO Section 24 consultation
-
Response to Department of Health consultation on regulations on mitochondrial donation
-
Joint response to Department of Health consultation on Medical Innovation Bill
-
Joint statement supporting funding for stem cell and reproductive health research in Europe
-
Letter to Health Research Authority on supporting student research
-
Response to Home Office Section 24 consultation
-
MEPs pledge briefing: Investment
-
MEPs pledge briefing: Research
-
MEPs pledge briefing: Health
-
MEPs pledge briefing: Access
-
European pledge card for MEPs
-
National Health Screening: HOC S&T Committee inquiry
-
Draft R&D strategy: NHS England consultation
-
Response to NHS England research and development strategy consultation
-
Joint statement on LIBE Committee's amendments to EU Data Protection Regulation
-
Joint statement on genome editing in human cells
-
Response to ONS census consultation
-
Antimicrobial resistance: Academy endorsed IAP/IAMP academies statement
-
Antimicrobial resistance: Academy response to select committee inquiry
-
Response to Nuffield Council on Bioethics consultation on ethical issues for children and clinical research
-
Public Health England: HoC Health Committee inquiry
-
Joint submission to the EU Balance of Competencies Review
-
European Clinical Trials Regulation: Joint position on the possible inclusion of ICHGCP
-
Joint response to EMA consultation on publication and access to clinical trial data
-
General Medical Council academic training review
-
BIS EU Balance of Competences consultation joint-Academies response
-
Openness on animal research: Declaration on a new Concordat
-
'Government strategic priorities for science and research funding': joint Academies consultation response
-
Academy open letter to the Prime Minister on anniversary of 2011 announcements
-
Academy response to Government review of progress toward Life Sciences Commitments December 2012
-
Government strategic priorities for science and research: Joint Academies response to Sir John O’Reilly’s consultation
-
European Clinical Trials Regulation: position on clinical study reports
-
Fuelling prosperity: Joint Academies statement
-
Triennial review of the research councils
-
Sense about Science letter on AllTrials
-
Response to House of Commons S&T Committee inquiry on clinical trials and disclosure of data
-
Joint submission to the Shape of Training review
-
Response to draft Care and Support Bill
-
Joint response to the MHRA consultation on European medical device legislation
-
Draft care and support bill: Joint scrutiny committee inquiry
-
Revision of European legislation on medical devices: MHRA public consultation
-
Strengthening the NHS constitution: Department of Heath consultation
-
Proposals for a European Clinical Trials Regulation: MHRA consultation
-
European Commission’s proposals for a clinical trials regulation: MHRA consultation
-
Response to Human Fertilisation & Embryology Authority public consultation on mitochondria replacement
-
European Clinical Trials Regulation: joint statement
-
Draft Care and Support Bill: Department of Health Consultation
-
Letter to the Minister for government policy regarding consultation principles
-
Early access to medicines scheme: MHRA consultation
-
The future of higher education in England: Institute for Public Policy Research consultation
-
Proposal to transfer functions from the HFEA and the HTA: Department of Health consultation
-
Draft mandate to the NHS Commissioning Board: Department of Health consultation
-
Draft anonymisation codes of practice: Information Commissioner's Office
-
Draft mandate to the NHS Commissioning Board: Department of Health consultation
-
Stem cell research and Horizon 2020: Academy endorsed statement
-
Joint statement on the proposals for the European Data Protection Regulation
-
Future of the HoL S&T Committee: Joint Academies letter to the Prime Minister
-
Academy contribution to the review of Liberal Democrat Science Policy
-
Bridging the 'valley of death': Evidence to the HOC S&T Committee inquiry
-
NHS reforms: Peers' letter to Earl Howe
-
Science and engineering assurance: Foreign and Commonwealth Office review
-
Letter to the Prime Minister in response to Government Life Sciences Commitments
-
Higher education in Science Technology Engineering and Mathematics (STEM) subjects: HOL S&T Committee inquiry
-
Physical Agents Directive: Academy endorsed FEAM statement
-
NHS reforms: Briefing on amendments ahead of Committee Stage in the House of Lords
-
Water and health: Academy endorsed G8+ science academies statement
-
Response statement on the NHS Innovation Review
-
UK Government's innovation and research strategy
-
Health related aspects of the life sciences sector: Office for Life Sciences review
-
NHS reforms: Briefing on embedding research in the NHS
-
Science as a public enterprise: Royal Society consultation
-
Transposition of European Directive 2010/63/EU on the protection of animals used for scientific purposes
-
NHS reforms: Letter to the President from the Secretary of State
-
Revision of the EU Clinical Trials Directive 2001/20/EC
-
Revision of the EU Clinical Trials Directive: Academy endorsed statement by non-commercial research organisations
-
NHS reforms: Joint submission to the Future Forum
-
Research and innovation: FEAM response to EU consultation
-
Revision of the EU Clinical Trials Directive - Academy endorsed FEAM response
-
Peer Review: HOC S&T Committee inquiry
-
Letter to Health Secretary on treatments to avoid transmission of mitochondrial disease
-
Public Health White Paper: Department of Health consultation
-
Developing the healthcare workforce: Department of Health consultation
-
Science and international development: HOC S&T Committee's inquiry
-
NHS reforms: Response to the information strategy consultation
-
Health co-benefits of policies to tackle climate change: Inter Academy Medical Panel Statement
-
NHS reforms: Letter to the Secretary of State for Health on the public health strategy
-
NHS reforms: Response to the public health consultation
-
NHS outcomes framework
-
The health of women and children: Academy endorsed G8+ science academies statement
-
Biomedical research - a platform for increasing health and wealth in the UK
-
Academy second submission to spending review 2010
-
Academy first submission to the Science spending review 2010
-
NHS reforms: Letter to the Secretary of State for Health on the NHS Outcomes Framework
-
Clinical Trials Directive 2001/20/EC: European Commission consultation - Academy endorsed FEAM statement
-
European and Developing Country Clinical Trials Partnership
-
Review of compensation levels, incentives and the Clinical Excellence and Distinction Award schemes for NHS consultants
-
Innovation Pass Pilot: Department of Health consultation
-
Guidelines on Scientific Analysis in Policy Making: Department of Business, Innovation and Skills consultation
-
Clinical Trials Directive 2001/20/EC: European Commission consultation
-
Clinical Trials Directive 2001/20/EC: European Commission consultation - Academy endorsed FEAM response
-
GMC/PMETB merger: Draft rules and regulations consultation
-
Postgraduate training: Department for Business, Innovation and Skills consultation
-
Research Excellence Framework: Higher Education Funding Council for England consultation
-
Complementary and alternative medicine: HOL Select Committee Inquiry
-
Principles for the treatment of independent scientific advice: HOC S&T Committee inquiry
-
Disclosure of information for research purposes: Department of Health consultation:
-
Statement on mitigating climate change
-
Responsible Officer regulations and guidance: Department of Health consultation
-
Response to Academy of Medical Royal Colleges’ consultation on specialist standard frameworks for revalidation
-
Putting science and engineering at the heart of government policy: Innovation, Universities and Skills Select Committee
-
Eliminating world poverty: Department for International Development consultation
-
Hype, hope and hybrids: perspectives of the Human Fertilisation and Embryology Bill and its passage through Parliament
-
Proposals for a centre of excellence: The King's Fund consultation
-
NHS constitution: Department of Health consultation
-
A vision for science and society: Department of Innovation, Universities and Skills consultation
-
Innovation in services: Royal Society consultation
-
Dementia - ethical issues: Nuffield Council on Bioethics consultation
-
Drug resistant tuberculosis: EASAC call for evidence
-
Genomic medicine: HOL S&T Committee inquiry
-
Response to Ministry of Justice data sharing review
-
Acting through intergovernmental organisations to control the spread of communicable diseases: HOL Ad Hoc Committee
-
Biosecurity in UK research laboratories: Innovation, Universities and Skills Select Committee inquiry
-
NHS Next Stage Review: Innovation
-
Aspiring to excellence: Response to the report of the independent inquiry into modernising medical careers
-
MHRA: Challenges and priorities for the next 5 years
-
MMC England Board consultation: Proposals for improvements in 2008
-
Response to Sir David Cooksey's review of UK health research
-
Transplantation research integration in Europe
-
Statement on academic boycotts
-
Inquiry in to NICE: HOC Health Committee
-
Response to UKCRC consultation on developing the best research professionals
-
Electronic patient record: HOC Health Committee inquiry
-
Use of science in the Home Office: Office of Science and Innovation consultation
-
Efficiency and effectiveness of peer review project: Research Councils UK consultation
-
The Cooksey review: HOC S&T Committee inquiry
-
Good doctors, safer patients: Chief Medical Officer consultation
-
Public health - ethical issues: Nuffield Council on Bioethics consultation
-
Sir David Cooksey's Review of UK Health Research
-
Reform of research funding and assessment: Department for Education and Skills
-
Joint response to the Cooksey Review of UK Health Research
-
Microbiology & infectious diseases research: UKCRC consultation
-
Operation of NHS research ethics committees: COREC/NPSA consultation
-
Human Fertilisation & Embryology Act: Department of Health review
-
Universal ethical code for scientists: Council of Science & Technology consultation
-
Best research for best health: Department of Health consultation
-
Mental Capacity Bill: HOL briefing
-
Human Tissue Act: HTA consultation
-
Public Health White Paper: HOC Health Select Committee
-
The future of the National Institute for Medical Research: HOC S&T Committee inquiry
-
Science spending: HM Treasury consultation
-
Response to House of Lords S&T committee inquiry on scientific aspects of ageing
-
Choosing health: Department of Health consultation
-
RAE 2008 panel configuration and recruitment: HEFCE/Department of Employment and Learning Northern Ireland consultation
-
Science and innovation: working towards a ten-year investment: HM Treasury/DTI/DfES consultation
-
Statement on the Human Tissue Bill
-
Research funding methods: HEFCE consultation
-
Reform of Research Assessment
-
Reform of the senior house officer grade: NHS consultation
-
Unclaimed and unidentifiable organs and tissue: Retained Organs Commission consultation
-
Infectious diseases in livestock: Royal Society inquiry
-
Stem cell research: HOL S&T Committee Inquiry
-
Joint statement on transmissible spongiform encephalopathies
-
Structure, constitution and governance of the General Medical Council
-
Revalidating doctors; ensuring standards, securing the future: GMC consultation
-
Research policy and funding: NHS call for evidence
-
Support for science: NHS consultation
-
Joint submission to House of Lords S&T inquiry on the use of cannabis and its derivatives for medical and recreational purposes
Workshop, symposium and lecture reports
-
FORUM: Enabling greener biomedical research executive summary and next steps
-
FORUM: Enabling greener biomedical research full report
-
The contribution of cross-sector mobility to the sustainability of health research in the UK
-
Researcher capacity building: Supporting the career development of emerging research leaders in Africa workshop report
-
Advancing mental health research in Sub-Saharan Africa workshop report
-
Climate change and global public health: 2022 Richard and Hinda Rosenthal Symposium (Full report)
-
FORUM: chronic pain - experimental insights and clinical insights full report
-
FORUM: Clinical trials for rare diseases - summary for people living with rare conditions
-
FORUM: Clinical trials for rare diseases - full report
-
FORUM: Clinical trials for rare diseases - executive summary, innovations & next steps
-
Our microbes, our health: Current research on the human microbiome
-
IAP and AMS Global Health Inequalities Communique
-
Global Health Inequalities: Research for a fairer future
-
FORUM: Diagnostics, building capacity and capability in the UK - full report
-
2021 FORUM Sir Colin Dollery Lecture report
-
FORUM: women's health - a life course approach workshop full report
-
FORUM: Antimicrobial resistance research: learning lessons from the COVID-19 pandemic - full report
-
FORUM: Antimicrobial resistance research: learning lessons from the COVID-19 pandemic - full report
-
FORUM: Antimicrobial resistance research: learning lessons from the COVID-19 pandemic - short summary
-
FORUM: Diagnostics, building capacity and capability in the UK - summary
-
FORUM Sir Colin Dollery Lecture - agenda
-
FORUM: Women's health - a life course approach workshop summary
-
FORUM: Advancing regulatory science for innovative medical products
-
FORUM: Advances in antimicrobial innovation
-
What other awardees said - COVID-19 impact summary
-
Progress and priorities for mental health sciences since COVID-19
-
FORUM: Cross-sector opportunities for developing new interventions for patients with multiple long-term conditions
-
FORUM: Building a sustainable UK diagnostics sector
-
FORUM: Precision prevention for modifiable health risks
-
GCRF workshop: Addressing the challenges of anaemia in the Andean region - full report
-
Health and Internal Displacement workshop - executive summary
-
Health and Internal Displacement - workshop report
-
Advancing universal health coverage in the Middle East and North Africa - Executive summary (Arabic)
-
GCRF workshop: UHC & Quality of care in Latin America - full report (Spanish)
-
GCRF workshop: UHC & Quality of care in Latin America - summary
-
GCRF workshop: UHC & Quality of care in Latin America - full report
-
GCRF workshop - UHC in Nigeria - full report
-
Universal Health Coverage in the Middle East and North Africa: The role of research DRAFT programme Day Two
-
Lessons learnt: the role of academia and industry in the UK’s diagnostic testing response to COVID-19 - full report
-
Lessons learnt: the role of academia and industry in the UK’s diagnostic testing response to COVID-19 – accessible summary
-
Implementing the Academy’s ‘Strengthening academic psychiatry in the UK’ report
-
Remote and digital mental health interventions and COVID-19
-
FORUM: Public involvement and engagement in research during the COVID-19 pandemic
-
GCRF workshop: Addressing the COVID-19 pandemic in LMICs - summary
-
GCRF workshop: Addressing the COVID-19 pandemic in LMICs - full report
-
GCRF workshop: Non-communicable diseases in South Asia and beyond - summary
-
GCRF workshop: Non-communicable diseases in South Asia and beyond - full report
-
FORUM: Healthy ageing conference report
-
Coordinating the collection of high-quality data on the mental, cognitive and neurological health impacts of COVID-19
-
GCRF workshop: Urban Health Research in Latin America - summary
-
GCRF workshop: Urban Health Research in Latin America - full report
-
FORUM: Shaping the future training and employment environment for clinical research
-
GCRF workshop: Addressing the social determinants of global mental health - summary
-
GCRF workshop: Interdisciplinary research in epidemic preparedness and response - summary
-
GCRF workshop: Improving the prevention and management of multimorbidity in sub-Saharan Africa - summary
-
GCRF workshop: Early intervention and diagnosis in paediatric neurodevelopmental disorders in Brazil - summary
-
GCRF workshop: Improving the development and deployment of rapid diagnostic tests in LMICs - summary
-
GCRF workshop: Addressing the social determinants of global mental health - full report
-
Challenges and priorities for global mental health research in LMICs - full report
-
Realising patient and NHS benefits from health and care data - from policy to practice
-
UK-Japan symposium on data-driven health
-
GCRF workshop: Interdisciplinary research in epidemic preparedness and response - full report
-
GCRF workshop: Improving the prevention and management of multimorbidity in sub-Saharan Africa - full report
-
From subjects to partners: putting patients at the heart of medical research
-
Clinical academia for the future: research leaders and innovators
-
FORUM Annual Lecture: The promise of human genome editing for rare and genetic disease
-
Artificial intelligence and health report
-
AI in health and care: from bench to bedside
-
£30,000 salary threshold explainer document - UK National Academies
-
End of life and palliative care: the policy landscape
-
End of life and palliative care: background briefing
-
GCRF workshop: Improving the development and deployment of diagnostics in Southeast Asia - full report
-
FORUM Annual Lecture: Transforming healthcare through engineering and technology
-
Horizon scanning: what's next for medical and health research?
-
GCRF workshop: Maternal and newborn survival in sub-Saharan Africa - full report
-
FORUM: Delivering novel therapies in the 21st century
-
Patient data and future data-driven technologies implications
-
Advancing research to tackle multimorbidity: the UK and LMIC perspectives - full report
-
GCRF workshop: Challenges and priorities for global mental health research - full report
-
Controlled Human Infection Model studies
-
FORUM: Accelerating the translation of early detection and diagnosis research in cancer
-
FORUM: Bridging the preclinical-clinical boundary
-
Principles for evidence synthesis
-
Exploring Good Clinical Practice guidance in clinical trials – meeting summary
-
Evidence synthesis for policy
-
FORUM: Next steps for using real world evidence
-
GCRF workshop: Addressing the global health challenge of obesity in Malaysia - full report
-
FORUM: Accelerating access to medical innovation
-
Medical research: what's it worth? A policy briefing
-
FORUM: Oncology endpoints in clinical research
-
GCRF workshop: Strengthening clinical research capacity in LMICs - summary
-
GCRF workshop: Strengthening clinical research capacity in LMICs - full report
-
FORUM: Personalised psychiatry
-
The future of public health research
-
Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines: next steps
-
FORUM: Digital maturity of health and social care systems
-
GCRF workshop: Multimorbidity lessons from the BRICS countries
-
FORUM: Exemplar clinical pathways for a stratified approach to severe asthma
-
FORUM Annual Lecture: The mind-body interface
-
FORUM: Regulation and governance of health research - five years on
-
GCRF workshop: Improving the development and deployment of rapid diagnostic tests in LMICs - full report
-
FORUM: Health economics for stratified medicine
-
GCRF workshop: Multimorbidity lessons from South Africa - full report
-
GCRF workshop: Multimorbidity lessons from South Africa - summary
-
FORUM: Geographical clusters: a vision for the future
-
FORUM: UK drug discovery landscape
-
FORUM: Influencing the trajectories of ageing
-
Forced migrant health: priorities for health research
-
Joint workshop on the ICMJE proposal on sharing clinical trial data
-
FORUM: Exemplar clinical pathways for a stratified approach to cardiovascular disease
-
FORUM: Exemplar clinical pathways for a stratified approach to diabetes
-
Perspectives on 'Communicating evidence about medicines' workshop report
-
Perspectives on 'Communicating evidence in the media' roundtable meeting report
-
Perspectives on 'Conflicts of interest' workshop report
-
FORUM Annual Lecture: What can research do to improve productivity in the NHS?
-
Real world evidence
-
Exploring a new social contract for medical innovation
-
Report on roundtable on multiple morbidities
-
Summary of International Health Lecture 2012
-
FORUM: Stratified, personalised or P4 medicine
-
International Health Lecture: Re-engineering personalised healthcare for chronic disease
-
Reproducibility and reliability of biomedical research: improving research practice
-
Accelerated access review: meeting note
-
FORUM Annual Lecture: A vision for the UK life sciences sector
-
Science without borders: European Commissioner for Research lecture report
-
FORUM: Health apps: regulation and quality control
-
Report of a meeting at the European Parliament on 'Understanding research using animals and the alternatives'
-
FORUM: Patient adherence to medicines
-
Discussion with the Health Research Authority meeting note
-
Discussion with the Health Research Authority_HRA Approval update
-
Data in safe havens
-
FORUM: Horizon scanning: looking ahead to 2025
-
Improving the status and valuation of teaching in the careers of UK academics (2014): Annex - Breakout groups table
-
Improving the status and valuation of teaching in the careers of UK academics (2014): Annex - Case study slides
-
Improving the status and valuation of teaching in the careers of UK academics (2014): Annex - Workshop agenda
-
Improving the status and valuation of teaching in the careers of UK academics (2014): Annex - Interpretation from survey
-
Improving the status and valuation of teaching in the careers of UK academics (2014): Project summary
-
Improving the status and valuation of teaching in the careers of UK academics (2014): Project summary
-
IHL 2014 Innovation in Global Health Slides - Dr Trevor Mundel
-
Innovation in Global Health - International Health Lecture 2014 Report
-
Medical Research: What’s it worth? Estimating the economic benefits of cancer-related research in the UK
-
Open Innovation in the NHS
-
APPG roundtable on building trust in the use of personal data for medical research
-
Joint meeting with US Institute of Medicine on how health systems respond to evolving challenges
-
Joint meeting with Dr John Landers, Chair of the 'Animals in Science' Committee
-
Research in the UK Public Health system - AMS/Public Health England November 2013 slides
-
Clinical trials data sharing: science, privacy and ethics
-
Realising the potential of stratified medicine - 8 Nov 2013 stakeholder meeting note
-
Discussion dinner with the Chair of NHS England
-
Research in the UK public health system
-
An audience with the HRA
-
FORUM Annual Lecture: The changing pharmaceutical industry and the opportunity for precision medicine
-
Establishing high-level evidence for the safety and efficacy of medical devices and systems
-
Public Health Research: Reflections from the CDC: Round-table discussion report
-
Independent evaluation of the Clinician Scientist Fellowship Scheme
-
Team science: a discussion paper
-
Human enhancement and the future of work: Joint Academies meeting report
-
Regenerative medicine regulations
-
Building institutions through equitable partnerships in golbal health: Conference report
-
Health Impacts of Product Development Partnerships: International Health Lecture 2012 report
-
Transforming the regulation and governance of health research in the UK - follow-up
-
Building institutions through equitable partnerships in global health: Conference report
-
FORUM Annual Lecture: Frameworks for the regulation of medicinal products
-
Look West: UK-Brazil tropical medicine and parasitology
-
FORUM Annual Lecture: Moving from 'made in China' to 'discovered in China'
-
Diabetes and obesity: getting to the heart of the matter: Meeting report
-
HIV and global health 2011: International Health Lecture 2010 report
-
FORUM: Academia, industry and the NHS - collaboration and innovation
-
FORUM: Research and development of medical products
-
Public dialogue into animals containing human material - evaluation report
-
Public dialogue into animals containing human material - full report
-
FORUM Annual Lecture: The importance of regulatory science to the healthcare portfolio
-
The Bologna Process: will it affect UK biomedicine and clinical science: Symposium report
-
Malaria elimination: feasible or futile?: International Health Lecture 2009 report
-
Global health perspectives
-
Research in general practice: bringing innovation into patient care: Symposium report
-
FORUM Annual Lecture: Pharmacogenetics - personalised safety and segmented efficacy
-
FORUM: Genome-wide association studies
-
Global health diagnostics: research, development and regulation
-
FORUM: Biotechnology innovation
-
Translating new research into clinical practice: Symposium report
-
FORUM: Biotechnology innovation - opportunities and challenges
-
FORUM Annual Lecture: The UK pharmaceutical industry - what does the future hold?
-
The freedom to succeed: Meeting report
-
FORUM: Optimizing stratified medicines R&D
-
Pandemic influenza: Follow up meeting report
-
FORUM Annual Lecture: The highs and lows of academic industrial collaborations
-
FORUM: Drug discovery symposium
-
Science of violence
-
Diseases of the developing world: working together to make a difference: Symposium report
-
Personal data for public good: legal symposium
-
FORUM Annual Lecture: The human genome - realising pharmaceutical opportunities
-
Strengthening health services research: Workshop report
-
FORUM Annual Lecture: Cancer research in the UK
-
Detection and identification of infectious disease: Workshop report
-
FORUM: Medicines for children
-
FORUM Annual Lecture: Can Europe compete in biomedical research?
-
FORUM: European clinical trials directive
-
FORUM Annual Lecture: Pharmacogenetics - personalised safety and segmented efficacy
-
Diet and diseases: facts and fantasies
Policy working group reports
-
Future-proofing UK Health Research - infographic
-
Future-proofing UK Health Research - full report
-
Future-proofing UK Health Research - public summary
-
Future-proofing UK health research - explainer
-
Future-proofing UK Health Research - executive summary
-
Future-proofing UK Health Research - case studies
-
The future of health research in the UK: An online dialogue project for the Academy of Medical Sciences
-
Strengthening clinical research - evidence summary
-
Preparing for a challenging winter 2020-21 - Ipsos MORI public dialogue
-
Preparing for a challenging winter 2020-21 - people's perspective
-
Preparing for a challenging winter 2020-21 - summary
-
Preparing for a challenging winter 2020-21 - full report
-
Tackling the impact of COVID-19 on mental health - summary
-
Transforming health through innovation: Integrating the NHS and academia - case studies
-
Economic analysis of the benefits of dedicated research time for hospital consultants in the NHS
-
Transforming health through innovation: Integrating the NHS and academia - summary
-
Transforming health through innovation: Integrating the NHS and academia
-
From innovation to implementation: team science two years on
-
Our data-driven future in healthcare - summary
-
Our data-driven future in healthcare - public dialogue
-
Our data-driven future in healthcare - full report
-
Multimorbidity: a priority for global health research - full report
-
Multimorbidity: a priority for global health research - summary
-
Sources of evidence for assessing medicines
-
Enhancing the use of scientific evidence - summary
-
Enhancing the use of scientific evidence - full report
-
Improving the health of the public by 2040
-
Improving recognition of team science contributions in biomedical research careers - full report
-
Use of neuraminidase inhibitors in influenza
-
Redressing the balance: the status and valuation of teaching in academic careers
-
Realising the potential of stratified medicine: case studies
-
Realising the potential of stratified medicine
-
Guidelines for monitoring academic training and progress
-
Guidelines for monitoring clinical academic training and progress
-
Animals containing human material - full report
-
Animals containing human materials - summary
-
A new pathway for the regulation and governance of health research
-
Redressing the balance: the status and valuation of teaching in academic careers
-
Reaping the rewards: a vision for UK medical science - summary
-
Reaping the rewards: a vision for UK medical science - full report
-
Revalidation for UK doctors: position paper
-
Rejuvenating ageing research
-
Building clinical academic capacity and the allocation of resources across academic specialties
-
Brain science, addiction and drugs - summary
-
Brain science, addiction and drugs - full report
-
Identifying the environmental causes of disease - full report
-
Identifying the environmental causes of disease - summary
-
Careers for biomedical scientists and clinicians in industry
-
Response to the Review of Modernising Medical Careers
-
MB PhD position paper
-
Inter-species embryos
-
Systems biology: a vision for engineering and medicine
-
Pandemic influenza: science to policy
-
Use of non-human primates in research
-
Medical research: assessing the benefits to society
-
Testing antibody therapies
-
Personal data for public good: using health information in medical research
-
Safer medicines
-
Microbial challenge studies of human volunteers
-
The freedom to succeed: non-clinical research fellowships in biomedical science
-
Restoring neurological function: putting the neurosciences to work in neurorehab
-
Calling time: the Nation's drinking as a major health issue
-
Strengthening clinical research
-
Severe acute respiratory syndrome (SARS)
-
Implementing the clinician scientist scheme
-
Clinical academic medicine in jeopardy: recommendations for change
-
Non-clinical scientists on short term contracts in medical research
-
Academic bacteriology in the 21st Century
-
Vaccines: current status and future needs
-
The tenure-track clinician scientist: a new career pathway to promote recruitment
-
Zinc cadmium sulphide dispersion trials
Corporate documents
-
Vice President (Clinical) 2023, role description
-
Academy Safeguarding Policy
-
Annual Report and Financial Statements 2021-22
-
Strategy 2022-2032: full-length document
-
Strategy 2022-2032: summary
-
Annual Report and Financial Statements 2020-21
-
Animals in research - case studies from the Academy of Medical Sciences
-
Equality, diversity and inclusion - 12 month action plan
-
Annual diversity report 2019-20
-
Annual Report and Accounts 2019-20
-
Royal Charter and Bye-Laws
-
COVID-19 - Q&A for applicants and award holders
-
Annual diversity report 2018-19
-
Annual Report 2018-19
-
Academy Disciplinary Regulations
-
Code of Conduct for Fellows working on Academy of Medical Sciences Business
-
Annual diversity report 2017-18
-
Academy of Medical Sciences Programmes Privacy Policy
-
Academy of Medical Sciences Privacy Policy
-
Annual Report 2017-18
-
Academy of Medical Sciences Grants Privacy Policy
-
Annual Report 2016-17
-
Annual diversity report 2016-17
-
Year in Review 2015-16
-
Annual Report and Accounts 2015-16
-
Annual Report 2014-15
-
Statutory Accounts 2014 - 2015
-
Annual Report and Accounts 2013-14
-
Annual report and full financial statements 2013-14
-
Annual Report 2012-13
-
Presidential perspectives - John Tooke
-
Improving health through research: Academy strategy 2012-16
-
Annual Report 2011-12
-
Supporting tomorrow's leaders today - mentoring booklet
-
Executive Directors review of the year 2010
-
Annual Report 2009-10
-
The global impact of medical science: an international strategy for the Academy of Medical Sciences
-
Academy review 2009
-
Survey of Fellows' communication experience
-
FORUM update summer 2007
-
Annual Report 2006-07
-
Academy review 2006
-
Strategic plan 2006-2010
-
Annual Report 2005-06
-
FORUM update autumn 2005
-
FORUM update winter 2004
-
Academy review 2004
-
FORUM update summer 2004
-
FORUM update summer 2003